These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33110015)

  • 21. Liver transplantation for hepatocellular carcinoma.
    Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
    J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma.
    Unzueta A; Cabrera R
    Clin Liver Dis; 2017 May; 21(2):231-251. PubMed ID: 28364811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underestimation of nodules while staging hepatocellular carcinoma prior to neoadjuvant treatment on waiting list for transplantation.
    Stippel DL; Kasper HU; Schleimer K; Benz C; Hölscher AH; Beckurts KT
    Transplant Proc; 2003 Jun; 35(4):1423-4. PubMed ID: 12826177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States.
    Kwong AJ; Ghaziani TT; Yao F; Sze D; Mannalithara A; Mehta N
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1142-1150.e4. PubMed ID: 34358718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downstaging Hepatocellular Carcinoma before Transplantation: Role of Immunotherapy Versus Locoregional Approaches.
    Lindemann J; Yu J; Doyle MBM
    Surg Oncol Clin N Am; 2024 Jan; 33(1):143-158. PubMed ID: 37945140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
    Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
    Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
    Sharr WW; Chan SC; Lo CM
    Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
    Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
    Cardiovasc Intervent Radiol; 2017 Mar; 40(3):410-420. PubMed ID: 27900445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma.
    Yilma M; Mehta N
    Surg Oncol Clin N Am; 2024 Jan; 33(1):133-142. PubMed ID: 37945139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Within the Milan Criteria.
    San Miguel C; Muffak K; Triguero J; Becerra A; Villegas T; Nogueras F; Expósito M; Fundora Y
    Transplant Proc; 2015 Nov; 47(9):2631-3. PubMed ID: 26680055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation and hepatocellular carcinoma 2023: a narrative review of management and outcomes.
    Tabrizian P; Holzner ML; Zaret D; Meyerovich G; Fagenson A; Schiano T
    Ann Palliat Med; 2024 Jan; 13(1):126-140. PubMed ID: 38124475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?
    Fujiki M; Aucejo F; Choi M; Kim R
    World J Gastroenterol; 2014 May; 20(18):5308-19. PubMed ID: 24833861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
    Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
    Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?
    Pillai AA; Ramanathan M; Kulik L
    Clin Liver Dis; 2020 Nov; 24(4):681-700. PubMed ID: 33012453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional therapy and recurrence of hepatocellular carcinoma after liver transplant.
    Kırnap M; Boyvat F; Akdur A; Karakayalı F; Arslan G; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():166-9. PubMed ID: 24635819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downstaging treatment for patients with hepatocelluar carcinoma before transplantation.
    Jiang G; Ling S; Zhan Q; Zhuang L; Xu X
    Transplant Rev (Orlando); 2021 Apr; 35(2):100606. PubMed ID: 33636480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.